Author: Ian SInclair

Training Pharmacy Technicians: Mastering Generic Drug Competency Standards

Posted by Ian SInclair On 30 Dec, 2025 Comments (1)

Training Pharmacy Technicians: Mastering Generic Drug Competency Standards

Pharmacy technicians must master generic drug names to prevent dangerous medication errors. Learn the standards, study methods, and real-world skills required for safe, accurate dispensing in today’s high-volume pharmacy environment.

How to Build a Personal Medication Safety Plan with Your Care Team

Posted by Ian SInclair On 28 Dec, 2025 Comments (2)

How to Build a Personal Medication Safety Plan with Your Care Team

Learn how to create a personal medication safety plan with your care team to prevent dangerous drug interactions, avoid missed doses, and reduce the risk of hospitalization. Simple steps can save your life.

How to Verify Drug Authenticity: Official Tools and Resources You Can Use

Posted by Ian SInclair On 27 Dec, 2025 Comments (4)

How to Verify Drug Authenticity: Official Tools and Resources You Can Use

Learn how to verify if your medicine is real using official tools like the EU’s FMD system, FDA resources, and pharmacist verification. Protect yourself from counterfeit drugs that could harm your health.

Selegiline Transdermal and Serotonergic Drugs: How to Avoid Dangerous Interactions

Posted by Ian SInclair On 26 Dec, 2025 Comments (5)

Selegiline Transdermal and Serotonergic Drugs: How to Avoid Dangerous Interactions

Selegiline transdermal (EMSAM) reduces dietary risks but still poses serious serotonin syndrome dangers when mixed with common antidepressants, painkillers, or OTC meds. Learn the exact washout periods, warning signs, and drug interactions you can't ignore.

Generic Drug Patents: How Exclusivity Periods Vary Around the World

Posted by Ian SInclair On 25 Dec, 2025 Comments (6)

Generic Drug Patents: How Exclusivity Periods Vary Around the World

Generic drug exclusivity periods vary widely by country, affecting how quickly affordable versions reach patients. The U.S. uses complex patent extensions and market protections, while Europe follows a more predictable 8+2+1 model. These rules shape global drug access and prices.

How Brand Manufacturers Produce Their Own Generic Versions

Posted by Ian SInclair On 24 Dec, 2025 Comments (4)

How Brand Manufacturers Produce Their Own Generic Versions

Brand manufacturers produce their own generic versions to protect revenue after patent expiry. These authorized generics are identical to the original drug but sold at lower prices, helping companies retain market share while offering patients familiar medication.

Inactive Ingredient Interactions in Generic Medication Combinations

Posted by Ian SInclair On 23 Dec, 2025 Comments (7)

Inactive Ingredient Interactions in Generic Medication Combinations

Inactive ingredients in generic medications can interact when taken together, causing side effects even when active ingredients are identical. Learn how fillers, dyes, and preservatives impact safety - and what to do about it.

Creating Your Personal Medication List: What to Include for Safety

Posted by Ian SInclair On 20 Dec, 2025 Comments (10)

Creating Your Personal Medication List: What to Include for Safety

A personal medication list prevents dangerous drug interactions and saves lives. Learn exactly what to include - from prescriptions to supplements - and how to keep it updated for maximum safety.

How to Calculate Total Cost of Therapy Beyond the Copay

Posted by Ian SInclair On 19 Dec, 2025 Comments (9)

How to Calculate Total Cost of Therapy Beyond the Copay

Therapy costs go far beyond your copay. Learn how deductibles, coinsurance, out-of-pocket maximums, and in-network vs. out-of-network providers affect your total bill - and how to plan your budget accurately.

Modified-Release Formulations: What You Need to Know About Bioequivalence Rules

Posted by Ian SInclair On 18 Dec, 2025 Comments (0)

Modified-Release Formulations: What You Need to Know About Bioequivalence Rules

Modified-release formulations require special bioequivalence testing because timing and rate of drug release matter. Learn how regulators like the FDA and EMA ensure generics work the same as brand-name drugs.